<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The underlying etiological cause of non-hereditary <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> has yet to be determined </plain></SENT>
<SENT sid="1" pm="."><plain>The <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence is widely accepted, however, a sole trigger has not been specified </plain></SENT>
<SENT sid="2" pm="."><plain>Therefore, we sought to further define genotypic and phenotypic parameters that could be involved in promoting a possible <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, <z:mp ids='MP_0001845'>inflammation</z:mp> and hyper-proliferation, followed by the <z:mpath ids='MPATH_270'>adenoma</z:mpath>-<z:mp ids='MP_0002038'>carcinoma</z:mp> sequence </plain></SENT>
<SENT sid="3" pm="."><plain>Expression of phenotype-related parameters for MHC class I (HLA-A N-20 and β2 microglobulin) and class II (HLA-DRα and HLA-DR) as well as CD45 and carcinoembryonic antigen (CEA) were investigated immunohistochemically in a series of 93 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancers</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Additionally, in 49 of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> the MHC class II genotype was analysed </plain></SENT>
<SENT sid="5" pm="."><plain>MHC class II genotype analyses revealed a tendency towards DRB1*08 and DQB1*04 </plain></SENT>
<SENT sid="6" pm="."><plain>A significant association among the MHC class I markers or the MHC class II markers was found </plain></SENT>
<SENT sid="7" pm="."><plain>No difference in marker expression could be detected between <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> and stromal tissue, however a significant inverse expression existed for markers of the functionally different class I or II systems </plain></SENT>
<SENT sid="8" pm="."><plain>With the exception of CEA, there was no correlation between expression of any marker and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> grade </plain></SENT>
<SENT sid="9" pm="."><plain>Only 2% of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumours</z:e> expressed no markers for MHC class I and II </plain></SENT>
<SENT sid="10" pm="."><plain>Further studies on MHC class I and II genotype and phenotype relation in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> may help to identify trigger mechanisms for <z:e sem="disease" ids="C1326912" disease_type="Neoplastic Process" abbrv="">tumourigenesis</z:e>, involved markers and possible mechanisms of subsequent immune escape </plain></SENT>
</text></document>